Hamilton Lane Inc Stock Price, News & Analysis

Cosette Pharmaceuticals has appointed Vincent Colicchio as Senior Vice President of Operations, effective February 3, 2025. Colicchio brings over 35 years of experience in pharmaceutical manufacturing and supply chain operations. Most recently, he served as Vice President of Supply Chain and External Manufacturing at Dr. Reddy's Laboratories, where he managed operations across North America and oversaw a network of more than 45 CMOs and CPOs.

In his previous role, Colicchio played a key role in acquiring and integrating Mayne Pharma's generics portfolio. His experience includes senior leadership positions at Amneal Pharmaceuticals, G&W Laboratories, GlaxoSmithKline, UCB Pharma, and Wyeth. At Cosette, he will lead manufacturing, global supply chain, and operational strategy to support the company's growth and transformation initiatives.

Hamilton Lane (Nasdaq: HLNE) announced the final close of its inaugural Venture Access Fund (VAF), raising $615.3 million in commitments, exceeding its $500 million target by 23%. The Fund targets top-performing, oversubscribed venture funds and companies, combining primary and secondary transactions to accelerate capital returns and mitigate the J-curve.

The fundraise attracted diverse global investors, including public and corporate pension funds, financial institutions, Taft-Hartley plans, family offices, and foundations. The Fund leverages Hamilton Lane's nearly 30-year venture investing experience and $117 billion in AUM and AUA across venture and growth equity.

The firm sees compelling opportunities in the current VC market, driven by AI and disruptive technologies, along with robust secondary market opportunities as companies stay private longer.

Hamilton Lane (HLNE) reported strong Q3 fiscal 2025 results, with total assets under management reaching $134.7 billion, representing a 12% year-over-year increase. The company's fee-earning assets grew by $7.9 billion to $71.0 billion.

Management and advisory fees rose 11% compared to the prior year period, reaching $126.3 million. The company's unrealized carried interest balance increased by 15% year-over-year to $1.3 billion. GAAP earnings per share stood at $1.32, with net income of $53.0 million for the quarter.

The company declared a quarterly dividend of $0.49 per share, targeting a full-year dividend of $1.96, marking a 10% increase from the previous fiscal year. Hamilton Lane's total assets under management and supervision reached $956.0 billion, comprising $134.7 billion in discretionary assets and $821.2 billion in non-discretionary assets.

Cosette Pharmaceuticals has appointed Brad Leonard as Vice President of Generics Commercial Operations to drive its next growth phase. Leonard will lead the company's generics business, including Sales, Marketing/Pricing, Customer Service, and Demand Planning. With over 30 years of pharmaceutical industry experience, Leonard previously contributed to Upsher-Smith Laboratories' success, earning multiple HDMA Diana Awards for product excellence and company performance.

President and CEO Apurva Saraf highlighted Leonard's deep industry expertise and track record in driving commercial success and strategic partnerships. Leonard, who holds a B.S. in Business Administration & Management from the University of Minnesota, expressed enthusiasm about joining Cosette during its period of accelerated growth and portfolio expansion.

Hamilton Lane's recent survey reveals a significant shift in private market investment trends, with 30% of investment advisors planning to allocate 20% or more to private markets in 2025, and another 29% planning 10%+ allocations. This represents a 15% increase from 2024.

Private infrastructure shows particular promise, with 48% of respondents planning to increase exposure, attracted by features like high barriers to entry, durable cash flows, and portfolio diversification. Private equity and credit remain top allocation choices.

The survey highlights that 76% of respondents view private markets as offering higher rewards compared to traditional investments, primarily driven by performance and diversification benefits. While 63% of advisors rate their private markets knowledge as 'advanced' (up from 55% last year), a knowledge gap persists.

Interest varies by generation, with highest engagement from Gen X (94%) and Millennials (89%). Geographically, Asia Pacific (51%) and the Americas (48%) show the strongest interest in private market investments.

Hamilton Lane (HLNE) and Republic announced a partnership to provide retail investors access to private market investments through digital blockchain-based solutions. The initiative aims to democratize access to a $13 trillion global market with low investment minimums and enhanced liquidity compared to traditional private market funds.

Hamilton Lane, managing $947 billion in assets, reports that private markets funds have outperformed public market equivalents in 19 of the last 20 years. The first offering is expected in 1H 2025. The partnership targets the significant opportunity in private markets, noting over 140,000 private companies with annual revenues exceeding $100 million, compared to approximately 19,000 public companies in the same revenue bracket.

Hamilton Lane (Nasdaq: HLNE) has announced it will release its third quarter fiscal 2025 financial results on Tuesday, February 4, 2025, before market opening. The company will host a conference call and webcast at 11:00 a.m. ET on the same day to discuss the results.

The company, which is one of the largest private markets investment firms globally, currently manages $947 billion in assets under management and supervision, comprising $131 billion in discretionary assets and $816 billion in non-discretionary assets as of September 30, 2024. With approximately 730 professionals across offices in North America, Europe, Asia Pacific and the Middle East, Hamilton Lane has been dedicated to private markets investing for over 30 years.

Hamilton Lane (Nasdaq: HLNE) has been named a 'Best Place to Work in Money Management' by Pensions & Investments for the 13th consecutive year since 2012, being one of only five firms to achieve this distinction consistently.

Throughout 2024, the firm received multiple industry recognitions including: PEWIN's North American LP of the Year for supporting women investors; WealthManagement.com awards for their AI venture Helix by HL and Knowledge Center; 'Private Equities Fund Manager of the Year' for their Global Private Assets Fund (AUD); 'Alternatives Manager of the Year' from Insurance Asset Risk Americas; and top recognition at the Canadian Hedge Fund Awards for three-year returns.

Chief Human Resources Officer Kristin Brandt emphasized the company's focus on fostering professional and personal development, while Co-CEOs Juan Delgado and Erik Hirsch highlighted their commitment to providing innovative investment solutions across private markets.

Hamilton Lane's Global Private Assets Fund (GPA) has won first place for three-year returns among private equity offerings at the 2024 Canadian Hedge Fund Awards, achieving a 14.33% annualized three-year return. The firm manages approximately $1.65 billion CAD for Canadian investors through evergreen products.

GPA, launched in 2019, has reached $6.7B CAD in global assets under management, including $1.3B in the Canadian feeder. The Fund provides diversification through direct equity, secondaries, and direct credit investments. Hamilton Lane's Canada Evergreen Platform also includes the Senior Credit Opportunities Fund and Global Private Infrastructure Fund.